- call +1-201-465-4211
- email sales@mrinsights.biz
Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average plasma glucose concentration. The test is limited to a three-month average because the lifespan of a red blood cell is four months (120 days). However, since red blood cells do not all undergo lysis at the same time, HbA1C is taken as a limited measure of three months. It is formed in a non-enzymatic glycation pathway by hemoglobin's exposure to plasma glucose.
Scope of the Report:
This report studies the Glycated Hemoglobin Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Glycated Hemoglobin Testing market by product type and applications/end industries.
High prevalence rate coupled with increasing incidence of diabetes among individuals in developed and developing economies are major factors driving growth of the global glycated hemoglobin testing market. In addition, growing awareness among diabetics for early diagnosis of diabetes so as to help in treatment & management of diabetes is another factor fueling growth of the global glycated hemoglobin testing market.
A major and rising trend in the global glycated hemoglobin testing market is increasing adoption of point-of-care testing for glycated hemoglobin testing by individuals across developed and in some developing economies. Access to results in substantially less amount of time as compared to that of lab based tests is a major factor for this increasing adoption.
The Americas will be the major revenue contributor to the hemoglobin A1C test throughout the forecast period. FActors such as the rising prevalence of diabetes and similar diseases, will fuel the steady growth of the market in this region.
The global Glycated Hemoglobin Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Glycated Hemoglobin Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott
Bio-Rad Laboratories
Danaher
EKF Diagnostics
F. Hoffmann-La Roche
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Lab Based Test
Point-of-Care Test
Market Segment by Applications, can be divided into
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Glycated Hemoglobin Testing Market Overview
1.1 Product Overview and Scope of Glycated Hemoglobin Testing
1.2 Classification of Glycated Hemoglobin Testing by Types
1.2.1 Global Glycated Hemoglobin Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Glycated Hemoglobin Testing Revenue Market Share by Types in 2017
1.2.3 Lab Based Test
1.2.4 Point-of-Care Test
1.3 Global Glycated Hemoglobin Testing Market by Application
1.3.1 Global Glycated Hemoglobin Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Academic and Research Institutes
1.4 Global Glycated Hemoglobin Testing Market by Regions
1.4.1 Global Glycated Hemoglobin Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Glycated Hemoglobin Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Glycated Hemoglobin Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Glycated Hemoglobin Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Glycated Hemoglobin Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Glycated Hemoglobin Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Glycated Hemoglobin Testing (2013-2023)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Glycated Hemoglobin Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Glycated Hemoglobin Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bio-Rad Laboratories
2.2.1 Business Overview
2.2.2 Glycated Hemoglobin Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bio-Rad Laboratories Glycated Hemoglobin Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Danaher
2.3.1 Business Overview
2.3.2 Glycated Hemoglobin Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Danaher Glycated Hemoglobin Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 EKF Diagnostics
2.4.1 Business Overview
2.4.2 Glycated Hemoglobin Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 EKF Diagnostics Glycated Hemoglobin Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 F. Hoffmann-La Roche
2.5.1 Business Overview
2.5.2 Glycated Hemoglobin Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 F. Hoffmann-La Roche Glycated Hemoglobin Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Glycated Hemoglobin Testing Market Competition, by Players
3.1 Global Glycated Hemoglobin Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Glycated Hemoglobin Testing Players Market Share
3.2.2 Top 10 Glycated Hemoglobin Testing Players Market Share
3.3 Market Competition Trend
4 Global Glycated Hemoglobin Testing Market Size by Regions
4.1 Global Glycated Hemoglobin Testing Revenue and Market Share by Regions
4.2 North America Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
4.5 South America Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
5 North America Glycated Hemoglobin Testing Revenue by Countries
5.1 North America Glycated Hemoglobin Testing Revenue by Countries (2013-2018)
5.2 USA Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
6 Europe Glycated Hemoglobin Testing Revenue by Countries
6.1 Europe Glycated Hemoglobin Testing Revenue by Countries (2013-2018)
6.2 Germany Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
6.3 UK Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
6.4 France Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Glycated Hemoglobin Testing Revenue by Countries
7.1 Asia-Pacific Glycated Hemoglobin Testing Revenue by Countries (2013-2018)
7.2 China Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
7.5 India Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
8 South America Glycated Hemoglobin Testing Revenue by Countries
8.1 South America Glycated Hemoglobin Testing Revenue by Countries (2013-2018)
8.2 Brazil Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Glycated Hemoglobin Testing by Countries
9.1 Middle East and Africa Glycated Hemoglobin Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Glycated Hemoglobin Testing Revenue and Growth Rate (2013-2018)
10 Global Glycated Hemoglobin Testing Market Segment by Type
10.1 Global Glycated Hemoglobin Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Glycated Hemoglobin Testing Market Forecast by Type (2018-2023)
10.3 Lab Based Test Revenue Growth Rate (2013-2023)
10.4 Point-of-Care Test Revenue Growth Rate (2013-2023)
11 Global Glycated Hemoglobin Testing Market Segment by Application
11.1 Global Glycated Hemoglobin Testing Revenue Market Share by Application (2013-2018)
11.2 Glycated Hemoglobin Testing Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Diagnostic Laboratories Revenue Growth (2013-2018)
11.6 Academic and Research Institutes Revenue Growth (2013-2018)
12 Global Glycated Hemoglobin Testing Market Size Forecast (2018-2023)
12.1 Global Glycated Hemoglobin Testing Market Size Forecast (2018-2023)
12.2 Global Glycated Hemoglobin Testing Market Forecast by Regions (2018-2023)
12.3 North America Glycated Hemoglobin Testing Revenue Market Forecast (2018-2023)
12.4 Europe Glycated Hemoglobin Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Glycated Hemoglobin Testing Revenue Market Forecast (2018-2023)
12.6 South America Glycated Hemoglobin Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Glycated Hemoglobin Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Glycated Hemoglobin Testing Picture
Table Product Specifications of Glycated Hemoglobin Testing
Table Global Glycated Hemoglobin Testing and Revenue (Million USD) Ma
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
